Results 131 to 140 of about 3,549 (185)

Bridging the preparedness gap: a systematic review of recommended stockpile items for radiological and nuclear emergencies. [PDF]

BMC Emerg Med
Nocci M, Bortolin M, Hertelendy AJ, Shaikh EA, Davis T, Serale M, Ragazzoni L, Issa F, Romagnoli S, DiGregorio D, Franc JM, Kung JY, Voskanyan A, Ciottone G.   +13 more
europepmc   +1 more source

Caught in the Crossfire: A Case of Splenic Infarction Amid G-CSF therapy in Chronic Myelomonocytic Leukaemia. [PDF]

Eur J Case Rep Intern Med
Peshin S, Rahimuddin B, Dharia A, Singh S, Kapadia C, Krishnadasan R.   +5 more
europepmc   +1 more source

What role for real-world evidence in market access of biosimilars? [PDF]

Front Pharmacol
Simoens S, Lockhart CM, Courmier DF.
europepmc   +1 more source

A new STAT3-based potency assay for human G-CSF analog therapeutics. [PDF]

J Pharm Biomed Anal
Xie T, Ouyang W, Zhang Y, Angart P, Lynch PJ, Frucht DM.   +5 more
europepmc   +1 more source

Immunomodulatory Agents and Factors in Poor Hematopoietic Stem Cell Mobilization: Current Strategies and Future Prospects. [PDF]

Stem Cell Rev Rep
Alipourfard I, Mokhtari T, Lesniak A, Saharkhiz S, Zelazewska Z.   +4 more
europepmc   +1 more source

An open-label, randomized study comparing lipegfilgrastim with filgrastim in pediatric patients receiving chemotherapy for Ewing sarcoma or rhabdomyosarcoma. [PDF]

Sci Rep
Belogurova MB, Lammerich A, Barkay H, Seo D, Buchner A.   +4 more
europepmc   +1 more source

Radiation emergency medical countermeasures: Current formulary, identified gaps, and future approaches. [PDF]

Animal Model Exp Med
Ma WB, Yin RH, Ren GM, Zhang Y, Li LJ, Liu W, Chen T, Zhou W, Zu M, Yin RL, Shi XD, Wang L, Yang XM.   +12 more
europepmc   +1 more source

Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients.

JAMA Netw Open
Riegler JS, Kesselheim AS, Rome BN.
europepmc   +1 more source

G-CSF-induced Aortitis Mimicking TIPIC Syndrome. [PDF]

Intern Med
Nagashima T, Yabe H, Sekiguchi Y.
europepmc   +1 more source

Successful Use of Epcoritamab in Refractory Diffuse Large B-Cell Lymphoma with Central Nervous System Involvement: A Case Report. [PDF]

Case Rep Oncol
Uemura Y, Togitani K, Nakashima J.
europepmc   +1 more source